Matthew Shea
Stock Analyst at Needham
(1.34)
# 3,525
Out of 4,352 analysts
35
Total ratings
43.5%
Success rate
-1.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Shea
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASTH Astrana Health | Rated: Buy | $30 → $41 | $37.62 | +8.98% | 3 | May 8, 2026 | |
| TOI The Oncology Institute | Reiterated: Buy | $5 | $4.69 | +6.61% | 6 | May 8, 2026 | |
| EVH Evolent Health | Reiterated: Buy | $4 → $5 | $3.95 | +26.58% | 11 | May 7, 2026 | |
| AGL agilon health | Reiterated: Hold | n/a | $92.28 | - | 8 | May 7, 2026 | |
| PRVA Privia Health Group | Reiterated: Buy | $30 | $21.51 | +39.47% | 7 | May 7, 2026 |
Astrana Health
May 8, 2026
Rated: Buy
Price Target: $30 → $41
Current: $37.62
Upside: +8.98%
The Oncology Institute
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $4.69
Upside: +6.61%
Evolent Health
May 7, 2026
Reiterated: Buy
Price Target: $4 → $5
Current: $3.95
Upside: +26.58%
agilon health
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $92.28
Upside: -
Privia Health Group
May 7, 2026
Reiterated: Buy
Price Target: $30
Current: $21.51
Upside: +39.47%